So-called convalescent plasma, which has long been used to treat diseases, has emerged as the latest political flashpoint in the race to find therapies for COVID-19. The U.S. FDA on Sunday authorized its use after President Donald Trump blamed the agency for impeding the roll-out of vaccines and therapeutics for political reasons.
